MiR-190 is upregulated in Epstein-Barr Virus type I latency and modulates cellular mRNAs involved in cell survival and viral reactivation

Virology

Volumn 464-465, Issue 1, 2014, Pages 184-195

  Cramer, Elizabeth M ^a   Shao, Ying ^a   Wang, Yan ^b   Yuan, Yan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

EBER RNAs; EBV; Latency; MiR 190; MiRNA; NR4A3; TP53INP1; Viral reactivation

Indexed keywords

MICRORNA; MICRORNA 190; NUCLEAR PROTEIN; PROTEIN TP53INP1; UNCLASSIFIED DRUG; MIRN190 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; BZLF1 GENE; CELL CYCLE G0 PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; EPSTEIN BARR VIRUS; G1 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE TARGETING; IMMEDIATE EARLY GENE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS LATENCY; VIRUS REACTIVATION; CELL LINE; EPSTEIN BARR VIRUS INFECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS ACTIVATION;

CELL LINE; CELL SURVIVAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MICRORNAS; UP-REGULATION; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84922393972     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.06.029     Document Type: Article

References (41)

1. Almog N., Briggs C., Beheshti A., Ma L., Wilkie K.P., Rietman E., et al. Transcriptional changes induced by the tumor dormancy-associated microRNA-190. Transcription 2013, 4(4):177-191. (Jul 1).
2. Babcock G.J., Hochberg D., Thorley-Lawson A.D. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 2000, 13(4):497-506. (Oct).
3. Banerjee S., Lu J., Cai Q., Saha A., Jha H.C., Dzeng R.K., et al. The EBV latent antigen 3C inhibits apoptosis through targeted regulation of interferon regulatory factors 4 and 8. PLoS Pathog. 2013, 9(5):e1003314. (May).
4. Beezhold K., Liu J., Kan H., Meighan T., Castranova V., Shi X., et al. miR-190-mediated downregulation of PHLPP contributes to arsenic-induced Akt activation and carcinogenesis. Toxicol. Sci. 2011, 123(2):411-420. (Oct).
5. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(32):11755-11760. (Aug 10).
6. Cameron J.E., Fewell C., Yin Q., McBride J., Wang X., Lin Z., et al. Epstein-Barr virus growth/latency III program alters cellular microRNA expression. Virology 2008, 382(2):257-266. (Dec 20).
7. Desbien A.L., Kappler J.W., Marrack P. The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(14):5663-5668. (Apr 7).
8. Ellis-Connell A.L., Iempridee T., Xu I., Mertz J.E. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J. Virol. 2010, 84(19):10329-10343. (Oct).
9. Forte E., Luftig M.A. The role of microRNAs in Epstein-Barr virus latency and lytic reactivation. Microbes Infect. 2011, 13(14-15):1156-1167. (Dec).
10. Forte E., Salinas R.E., Chang C., Zhou T., Linnstaedt S.D., Gottwein E., et al. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells. J. Virol. 2012, 86(12):6889-6898. (Jun).
11. Gironella M., Seux M., Xie M.J., Cano C., Tomasini R., Gommeaux J., et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(41):16170-16175. (Oct 9).
12. Gruhne B., Sompallae R., Marescotti D., Kamranvar S.A., Gastaldello S., Masucci M.G. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(7):2313-2318. (Feb 17).
13. Gruhne B., Sompallae R., Masucci M.G. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene 2009, 28(45):3997-4008. (Nov 12).
14. Haecker I., Gay L.A., Yang Y., Hu J., Morse A.M., McIntyre L.M., Renne R. Ago HITS-CLIP expands understanding of Kaposi[U+05F3]s sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog. 2012, 8(8):e1002884.
15. Hershko T., Chaussepied M., Oren M., Ginsberg D. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ. 2005, 12(4):377-383. (Apr).
16. Hughes D.J., Dickerson C.A., Shaner M.S., Sample C.E., Sample J.T. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency. J. Virol. 2011, 85(21):11435-11447. (Nov).
17. Jang K.L., Shackelford J., Seo S.Y., Pagano J.S. Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(51):18431-18436. (Dec 20).
18. Jiang P.H., Motoo Y., Garcia S., Iovanna J.L., Pebusque M.J., Sawabu N. Down-expression of tumor protein p53-induced nuclear protein 1 in human gastric cancer. World J. Gastroenterol. 2006, 12(5):691-696. (Feb 7).
19. 2007, Lippincott-Williams & Wilkins Publishers, Philadelphia. 5th ed. E. Kieff, D.M. Knipe, P.M. Howley (Eds.).
20. Komano J., Maruo S., Kurozumi K., Oda T., Takada K. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt[U+05F3]s lymphoma cell line Akata. J. Virol. 1999, 73(12):9827-9831. (Dec).
21. Lin Z., Wang X., Fewell C., Cameron J., Yin Q., Flemington E.K. Differential expression of the miR-200 family microRNAs in epithelial and B cells and regulation of Epstein-Barr virus reactivation by the miR-200 family member miR-429. J. Virol. 2010, 84(15):7892-7897. (Aug).
22. Marquitz A.R., Mathur A., Nam C.S., Raab-Traub N. The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology 2011, 412(2):392-400. (Apr 10).
23. Okamura S., Arakawa H., Tanaka T., Nakanishi H., Ng C.C., Taya Y., et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell 2001, 8(1):85-94. (Jul).
24. Qiu J., Cosmopoulos K., Pegtel M., Hopmans E., Murray P., Middeldorp J., et al. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog. 2011, 7(8):e1002193. (Aug).
25. Riley K.J., Rabinowitz G.S., Yario T.A., Luna J.M., Darnell R.B., Steitz J.A. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 2012, 31(9):2207-2221. (May 2).
26. Ruf I.K., Rhyne P.W., Yang H., Borza C.M., Hutt-Fletcher L.M., Cleveland J.L., Sample J.T. Epstein-Barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma. Mol. Cell. Biol. 1999, 19(3):1651-1660. (Mar).
27. Seto E., Moosmann A., Gromminger S., Walz N., Grundhoff A., Hammerschmidt W. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog. 2010, 6(8):e1001063. (Aug 19).
28. Shibuya H., Iinuma H., Shimada R., Horiuchi A., Watanabe T. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 2010, 79(3-4):313-320.
29. Skalsky R.L., Corcoran D.L., Gottwein E., Frank C.L., Kang D., Hafner M., et al. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 2012, 8(1):e1002484. (Jan).
30. Thompson M.P., Kurzrock R. Epstein-Barr virus and cancer. Clin. Cancer Res. 2004, 10(3):803-821. (Feb 1).
31. Thorley-Lawson D.A. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 2001, 1(1):75-82. (Oct).
32. Tomasini R., Samir A.A., Carrier A., Isnardon D., Cecchinelli B., Soddu S., et al. TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity. J. Biol. Chem. 2003, 278(39):37722-37729. (Sep 26).
33. Tomasini R., Seux M., Nowak J., Bontemps C., Carrier A., Dagorn J.C., et al. TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 2005, 24(55):8093-8104. (Dec 8).
34. Vereide D.T., Seto E., Chiu Y.F., Hayes M., Tagawa T., Grundhoff A., et al. Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 2013, 18. (Mar).
35. Ye J., Gradoville L., Miller G. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line. J. Virol. 2010, 84(23):12405-12418. (Dec).
36. Yeung M.L., Yasunaga J., Bennasser Y., Dusetti N., Harris D., Ahmad N., et al. Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1. Cancer Res. 2008, 68(21):8976-8985. (Nov 1).
37. Yin Q., McBride J., Fewell C., Lacey M., Wang X., Lin Z., et al. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 2008, 82(11):5295-5306. (Jun).
38. Yin Q., Wang X., Fewell C., Cameron J., Zhu H., Baddoo M., et al. MicroRNA miR-155 inhibits bone morphogenetic protein (BMP) signaling and BMP-mediated Epstein-Barr virus reactivation. J. Virol. 2010, 84(13):6318-6327. (Jul).
39. Zhang C., Zhao J., Deng H. 17beta-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Mol. Cell. Biochem. 2013, 379(1-2):201-211. (Jul).
40. Zhang Y., Li M., Wang H., Fisher W.E., Lin P.H., Yao Q., et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J. Surg. 2009, 33(4):698-709. (Apr).
41. Zheng H., Chu J., Zeng Y., Loh H.H., Law P.Y. Yin Yang 1 phosphorylation contributes to the differential effects of mu-opioid receptor agonists on microRNA-190 expression. J. Biol. Chem. 2010, 285(29):21994-22002. (Jul 16).